RxDoctor Payments Data
★ My doctorsLook up a doctor →

Robert Davis

Optometrist · Pembroke Pines, FLNPI 1932234523

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $157,437 of the $216,517 with a category attached, or 72.7%. Johnson & Johnson Vision Care, Inc. accounts for 97.2% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $50,776, more than ten times the $3,323 reported in 2019. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$216,517in general payments, 2019–2025

Across 740 payments — averaging $292.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$210K
  • Alcon$3K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
  • ABB Con-cise Optical Group LLC$463
  • Bausch & Lomb Americas Inc.$450
  • AbbVie$431
  • plus $1K from 15 others

What the payments were for

  • Consulting fees$5,9753%
  • Speaking & faculty fees$157,43773%
  • Travel & lodging$39,49918%
  • Food & beverage$13,5936%
  • Entertainment$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson Vision Care, Inc.642$210,421
Alcon24$2,562
Bausch & Lomb, A Division Of Bausch Health US, LLC15$1,012
ABB Con-cise Optical Group LLC8$463
Bausch & Lomb Americas Inc.6$450
AbbVie(2 entities)16$431
NEW World Medical,inc.2$224
Coopervision Inc.4$178
Johnson & Johnson Surgical Vision, Inc.2$164
Amgen(2 entities)2$140
Biotissue Holdings Inc.1$102
Maculogix, Inc.3$65
Tarsus Pharmaceuticals, Inc.3$61
Thea Pharma Inc.2$43
Kala Pharmaceuticals, Inc.2$35
Visioneering Technologies, Inc.1$34
Novartis2$32
Dompe US, Inc.1$30
Optos, Inc.2$28
Harrow Eye, LLC1$26
Shire North American Group Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$216,517 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida →

Medicare billing

Part B allowed, 2024
$36,828
Medicare patients
208
Services billed
397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost42$375

Paid to pharmacies, not to this prescriber.

Other optometrist in Pembroke Pines

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →